Latest news
{{'Wed, 27 May 2026 09:00:00 -0400' | dateFormatUsFilter}}
Novo Nordisk advances cardiometabolic pipeline with new data featuring CagriSema and zenagamtide at the American Diabetes Association's 2026 Scientific Sessions
Read more
{{'Thu, 07 May 2026 07:00:00 -0400' | dateFormatUsFilter}}
Wegovy® access expanded for Medicare beneficiaries living with obesity through the Medicare GLP-1 Bridge starting July 1, 2026
Read more
{{'Wed, 06 May 2026 05:34:00 -0400' | dateFormatUsFilter}}
Financial report for the period January 1, 2026 to March 31, 2026
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.